This will create a learning exchange between the different divisions of the company -- Alcon should not merely be imposing its organizational structure and philosophy upon CIBA. For the next year the two companies should have such an exchange of ideas. This will also quell another problem with mergers -- the resentment of the smaller entity that the larger company destroys the atmosphere, ethos, and fellowship of the merged unit.
Solution 3: Mixing insider and outsider information
Change-resistance after a merger is inevitable, but is considerably more apt to occur if the new managers are perceived as 'outsiders' versus the 'insiders' of the formerly independent company. Alcon must solicit information from ordinary CIBA Vision workers as well as high-level staff and use their input in the structure and timing of new solutions. This creates a positive sense of togetherness between current CIBA employees and new Alcon managers, and prevents an 'us vs. them'...
Once again, due to problems with the supplier, the product was unavailable through conventional pharmacies and the cost of a bottle of Miraflow (20 mL) skyrocketed from $6.00 to $30 on eBay -- an increase of 400%. This created a negative perception of a lack of affordability of CIBA's core products. CIBA took note of this problem and collaborated with I2, a supply chain company. It set the goal
Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while competing with other companies that manufacture products that treat similar afflictions and ailments. The complexities in drug research and development and regulations have created an industry that is subject to intense
Japanese-American Biopharmaceutical Industry in the 21st Century Optimizing Ethical Drug Availability Between These Two Pharmaceutical Superpowers" The Japanese-American biopharmaceutical industry represents an ongoing international effort between the two top pharmaceutical markets in the world. These two economic powers provide consumers with a majority share of all pharmaceuticals produced in the world. However, a number of pharmaceutical products that are currently available to U.S. residents are unavailable to Japanese consumers. From a humanitarian perspective, this
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now